Table 1.
Characteristics of 174 Fludarabine-Treated CLL Patients
Median age (yr) (range)
61 (25-84)
Male/female
110/64
Rai
I/II
59/49 (108)
III/IV
38/28 (66)
Time from diagnosis to Rx
9 mo (0-346)
B symptoms
16 (9%)
Performance status (0, 1, 2)
(93, 75, 6)
WBC ×10
3
/mL (range)
61.7 (5.1-430.0)
Prior infection
12 (7%)
Median age (yr) (range)
61 (25-84)
Male/female
110/64
Rai
I/II
59/49 (108)
III/IV
38/28 (66)
Time from diagnosis to Rx
9 mo (0-346)
B symptoms
16 (9%)
Performance status (0, 1, 2)
(93, 75, 6)
WBC ×10
3
/mL (range)
61.7 (5.1-430.0)
Prior infection
12 (7%)
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal